Congratulations to the WVU Clinical trials Research Unit (CTRU) and Dr. Adham Salkeni, WVU’s principal investigator for the NRG Oncology group, the largest clinical trials collaborative network in the United States. During the recent biannual meeting of the NRG, our CTRU was recognized as among the top ten main member sites to enroll the most patients on cancer clinical trials between January and June 2017. “This places WVU on the national map for clinical trials accrual,” Salkeni said. “This shows that we offer state-of-the-art research studies that examine the role of targeted therapies for the treatment of a wide variety of cancers that affect our patient population.”
Mike Ridinger joins WVU Cancer Institute as Assistant Director of Finance and Administration and Administrator of Hematology/Oncology
The WVU Cancer Institute welcomes Mike Ridinger, R.N., M.B.A., as assistant director of finance and administration and the administrator of Hematology/Oncology.
Rich Goldberg, M.D., director of the WVU Cancer Institute and Laurence S. and Jean J. DeLynn chair of Oncology, will step down from those positions and transition toward retirement once an interim is named or at the end of the calendar year.